CUCO - Pill reminder

59
CUCO - Pill reminder
CUCO - Pill reminder is an Android app from Cuco Health in the Medical category, currently rated 4.1★ across 4,279 ratings. Initial signal reads as mixed reviews: supporters praise core features while critics cite stability and value gaps.
Quality Score is 59: Solid (established niche player). For a Medical app, that means established niche player. The full BU Investment Matrix below scores 8 dimensions including monetisation, growth, and operational risk.
Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.
- Title & subtitle keyword fit
- Description hook & conversion structure
- Screenshots, ratings, reviews strategy
📊 Performance Tracking LIVE
Synthetic estimate. Inputs: category complexity, file size, screen count, monetization layer, platform reach, age × team-size proxy. Calibrated against 2024-2026 indie-agency rate surveys. Full math + source list on /methodology.
| 🧱 MVP baseline (design + 1-store ship) | +$28K |
| 📱 5 unique screens × $4.5K | +$22K |
| ⚙ Medical complexity ×1.55 | +$27K |
| 🌐 Cross-platform reach (iOS + Android) | +$43K |
Synthetic estimate. Multiple band derived from ad-supported + age, rating quality, category demand, and user-base maturity. Calibrated against 2024-2026 indie-app-marketplace closed-deal medians. Full math + comparable deal list on /methodology.
| 📺 Ad-supported base | 15× MRR |
| 🏷 Medical category multiple | +12% |
Synthetic estimate from ratings × category benchmarks. Calibrated against 2024-2026 mobile-attribution retention + DAU/MAU reports. Numbers are US-storefront-equivalent — true global audience can be 5-10× larger for international apps. Full math + source list on /methodology.
| 📲 Medical engagement | ~55 installs / rating |
| 🔁 Medical D30 retention | 25% |
| 📍 DAU / MAU stickiness | 0.20 |
How we forecast this revenue
LOW CONFIDENCEBU Investment Matrix
Early-stage solo · 41/100INDIE TIERexpected for tier- 💰 Revenue: Marginal — $317 - $1987/mo · INDIE tier · medium confidence, trajectory unclear.
- ⭐ Quality: 4.08★ across 4,279 reviews — solid.
- 📍 Market: Not yet charting in any of the 9 monitored markets.
- 📈 Growth: last update 251d ago — slow cadence.
- ⚠️ Risk: Low — no material risk signals detected.
💰 Forecast Revenue / mo
MODEL| bugsREVIEW | −$1,800 | |
| 5 starREVIEW | +$1,800 | |
| excellent appREVIEW | +$1,500 | |
| Low install base (4,279 ratings)METRIC | +$1,500 | |
| Mature app (9y old)METRIC | +$1,500 | |
| Good rating (4.1★)METRIC | +$800 | |
| Ad-supported / freemiumMETRIC | +$600 |
📈 Reviews Growth
LIVE⭐ Rating Trend
LIVEProfile & Insights
Identification
- App name
- CUCO - Pill reminder
- Developer
- Cuco Health
- Bundle ID
- br.com.drcuco
- App Store URL
- Open in App Store
- Category
- Medical
- Content rating
- Not found
- Languages
- Not found
Company
- Website
- www.cucohealth.com
- Tagline
- Not found
- Description
- Not found
- Founded
- Not found
- HQ / Address
- Not found
- Employees
- Not found
- Logo
- Not found
Revenue
- Verified revenue / mo
- Not found
- AI revenue estimate / mo
- Not found
- AI annual estimate
- Not found
- ML model estimate / mo
- $201/mo
- Top-grossing rank
- Not found
- All-time revenue
- Not found
- Pricing
- Not found
Founder
Funding
Press & Links
Contacts & Socials
📝 About this app
Do you find it difficult to take your medication on time? Are you going to do a bariatric surgery or do you want to take better care of your epilepsy? Then this app was made for you!
With CUCO you can:
Accompany each step of your journey to bariatric surgery with bari+, record your consultations, exams and authorization for bariatric surgery, and may even have the support of your partner in the process. In addition, you can also monitor your weight. Go to My Journey Bari+ and check it out.… View full description on the official store →
Tech & Domain Intel — cucohealth.com
- Mail provider
- Google Workspace
- Tech stack
- Google Workspace
Track this app’s revenue
FREE📝 Description
95
Why medium confidence: 4,279 ratings · no founder-verified revenue (model estimate only).



